LU67790A1 - - Google Patents

Info

Publication number
LU67790A1
LU67790A1 LU67790A LU67790DA LU67790A1 LU 67790 A1 LU67790 A1 LU 67790A1 LU 67790 A LU67790 A LU 67790A LU 67790D A LU67790D A LU 67790DA LU 67790 A1 LU67790 A1 LU 67790A1
Authority
LU
Luxembourg
Application number
LU67790A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU67790A1 publication Critical patent/LU67790A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
LU67790A 1972-06-15 1973-06-14 LU67790A1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
LU67790A1 true LU67790A1 (enExample) 1973-08-16

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
LU67790A LU67790A1 (enExample) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (enExample)
CA (1) CA1040619A (enExample)
DE (1) DE2330342A1 (enExample)
DK (1) DK136157B (enExample)
FR (1) FR2189034B2 (enExample)
GB (1) GB1434919A (enExample)
LU (1) LU67790A1 (enExample)
NL (1) NL7308267A (enExample)
ZA (1) ZA734037B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169832A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
HRP20210610T1 (hr) * 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP4275748A3 (en) 2014-10-16 2024-01-03 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3885352B1 (en) 2014-10-16 2024-11-27 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (de) * 1942-04-25 1951-02-28 Nv Organon Verfahren zur Herstellung einer im Ring C eine sauerstoffhaltige Gruppe enthaltenden Verbindung der Cyclopentanopolyhydrophenanthren-Reihe.
CH616691A5 (en) * 1970-12-17 1980-04-15 Glaxo Lab Ltd Process for the preparation of steroid compounds and their use.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof

Also Published As

Publication number Publication date
CA1040619A (en) 1978-10-17
AU5693773A (en) 1974-12-19
FR2189034B2 (enExample) 1977-01-21
GB1434919A (en) 1976-05-12
FR2189034A2 (enExample) 1974-01-25
DK136157B (da) 1977-08-22
DK136157C (enExample) 1978-01-23
DE2330342A1 (de) 1974-01-17
ZA734037B (en) 1974-05-29
NL7308267A (enExample) 1973-12-18
BE800899R (fr) 1973-12-14

Similar Documents

Publication Publication Date Title
JPS5631808B2 (enExample)
JPS5218527Y2 (enExample)
CS151398B1 (enExample)
CS151679B1 (enExample)
CS151836B1 (enExample)
CS151863B1 (enExample)
CS152719B1 (enExample)
CS152248B1 (enExample)
CS152246B1 (enExample)
CS152200B1 (enExample)
CS152035B1 (enExample)
CH567944A5 (enExample)
CH572192A5 (enExample)
CH564416A5 (enExample)
CH564688A5 (enExample)
CH564993A5 (enExample)
CH565230A5 (enExample)
CH565539A5 (enExample)
CH565923A5 (enExample)
CH565971A5 (enExample)
CH566103A5 (enExample)
CH566861A5 (enExample)
CH566879A5 (enExample)
CH567512A5 (enExample)
CH560025A5 (enExample)